BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31173192)

  • 1. T7 peptide cytotoxicity in human hepatocellular carcinoma cells is mediated by suppression of autophagy.
    Liu F; Wang F; Dong X; Xiu P; Sun P; Li Z; Shi X; Zhong J
    Int J Mol Med; 2019 Aug; 44(2):523-534. PubMed ID: 31173192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy.
    Wang F; Dong X; Xiu P; Zhong J; Wei H; Xu Z; Li T; Liu F; Sun X; Li J
    Oncol Rep; 2015 Feb; 33(2):675-84. PubMed ID: 25483829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of the COX-2/PGE2 axis enhances the antitumor activity of T7 peptide
    Yang J; Zhong J; Zhou M; Zhou Y; Xiu P; Liu F; Wang F; Li Z; Tang Y; Chen Y; Yao S; Huang T; Liu T; Dong X
    Drug Deliv; 2021 Dec; 28(1):844-855. PubMed ID: 33928829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo.
    Zhang Q; Yang M; Qu Z; Zhou J; Jiang Q
    Biochem Biophys Res Commun; 2016 Nov; 480(3):334-340. PubMed ID: 27756618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy induction by xanthoangelol exhibits anti-metastatic activities in hepatocellular carcinoma.
    Yang X; Xie J; Liu X; Li Z; Fang K; Zhang L; Han M; Zhang Z; Gong Z; Lin X; Shi X; Gao H; Lu K
    Cell Biochem Funct; 2019 Apr; 37(3):128-138. PubMed ID: 30883849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells.
    Kwon HY; Kim JH; Kim B; Srivastava SK; Kim SH
    Arch Toxicol; 2018 Jan; 92(1):241-257. PubMed ID: 28676953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest.
    Wilson JM; Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
    J Surg Res; 2014 Oct; 191(2):280-5. PubMed ID: 24996256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P57-mediated autophagy promotes the efficacy of EGFR inhibitors in hepatocellular carcinoma.
    Li WY; Li Q; Jing L; Wu T; Han LL; Wang Y; Yu SZ; Nan KJ; Guo H
    Liver Int; 2019 Jan; 39(1):147-157. PubMed ID: 30178471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3‑kinase/protein kinase B pathway.
    Zhang B; Yin X; Sui S
    Oncol Rep; 2018 Nov; 40(5):2758-2765. PubMed ID: 30132535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
    You N; Liu W; Wang T; Ji R; Wang X; Gong Z; Dou K; Tao K
    Oncol Rep; 2012 Dec; 28(6):2091-100. PubMed ID: 22993037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells.
    Tsai SC; Yang JS; Peng SF; Lu CC; Chiang JH; Chung JG; Lin MW; Lin JK; Amagaya S; Wai-Shan Chung C; Tung TT; Huang WW; Tseng MT
    Int J Oncol; 2012 Oct; 41(4):1431-42. PubMed ID: 22858649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma.
    Yurdacan B; Egeli U; Eskiler GG; Eryilmaz IE; Cecener G; Tunca B
    Hum Exp Toxicol; 2019 Feb; 38(2):201-215. PubMed ID: 30084279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
    Yang J; Pi C; Wang G
    Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bafilomycin A1 induces caspase-independent cell death in hepatocellular carcinoma cells via targeting of autophagy and MAPK pathways.
    Yan Y; Jiang K; Liu P; Zhang X; Dong X; Gao J; Liu Q; Barr MP; Zhang Q; Hou X; Meng S; Gong P
    Sci Rep; 2016 Nov; 6():37052. PubMed ID: 27845389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma.
    Zai W; Chen W; Han Y; Wu Z; Fan J; Zhang X; Luan J; Tang S; Jin X; Fu X; Gao H; Ju D; Liu H
    Carcinogenesis; 2020 May; 41(3):345-357. PubMed ID: 31175354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.
    Han P; Li H; Jiang X; Zhai B; Tan G; Zhao D; Qiao H; Liu B; Jiang H; Sun X
    Mol Oncol; 2017 Mar; 11(3):320-334. PubMed ID: 28164434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
    Ye R; Dai N; He Q; Guo P; Xiang Y; Zhang Q; Hong Z; Zhang Q
    Biomed Pharmacother; 2018 Sep; 105():962-973. PubMed ID: 30021391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.